Aaron Wealth Advisors LLC Bei Gene, Ltd. Transaction History
Aaron Wealth Advisors LLC
- $964 Million
- Q2 2025
A detailed history of Aaron Wealth Advisors LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Aaron Wealth Advisors LLC holds 828 shares of BGNE stock, worth $187,715. This represents 0.02% of its overall portfolio holdings.
Number of Shares
828
Previous 736
12.5%
Holding current value
$187,715
Previous $166,000
12.65%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding BGNE
# of Institutions
295Shares Held
40.1MCall Options Held
111KPut Options Held
114K-
Baker Bros. Advisors LP New York, NY8.8MShares$1.99 Billion23.78% of portfolio
-
Capital International Investors Los Angeles, CA5.09MShares$1.15 Billion0.24% of portfolio
-
Primecap Management CO Pasadena, CA5.06MShares$1.15 Billion0.97% of portfolio
-
Baillie Gifford & CO3.63MShares$823 Million0.74% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.71MShares$615 Million0.09% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.5B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...